A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway

BACKGROUND: Esophageal carcinoma (EC) is one of the most deadly malignant tumors in the world. Surgery, combined with chemotherapy or radiotherapy, is the traditional strategy for the treatment of EC. Cisplatin (CDDP) is a common chemotherapy drug widely used to treat EC due to its powerful anti-tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jun, Wang, Yuezhen, Wang, Zhun, Xie, Tieming, Yan, Fengqin, Wang, Lei, Hua, Jianfeng, Wang, Fangzheng, Fu, Zhenfu, Ye, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798537/
https://www.ncbi.nlm.nih.gov/pubmed/35117782
http://dx.doi.org/10.21037/tcr-19-975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798537/
https://www.ncbi.nlm.nih.gov/pubmed/35117782
http://dx.doi.org/10.21037/tcr-19-975

Ejemplares similares